SIMILAR PATTERNS OF AMINO ACIDS FOR 3OXX_A_DR7A100_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)

Filter list by:

	Hit	Macromolecule/ Organism	Pfam	Res.	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1a6d	THERMOSOME (BETA SUBUNIT) (Thermoplasma acidophilum)	PF00118 (Cpn60_TCP1)	5	LEU B 449 ALA B 413 GLY B 499 VAL B 498 ILE B 445	None	1.12A	3oxxB-1a6dB: undetectable	3oxxB-1a6dB: 12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1bl5	ISOCITRATE DEHYDROGENASE (Escherichia coli)	PF00180 (Iso_dh)	5	LEU A 290 ALA A 312 ASP A 311 GLY A 319 PRO A 144	None None MG A 418 ( 3.9A) None None	1.24A	3oxxB-1bl5A: 0.0	3oxxB-1bl5A: 13.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1cnz	PROTEIN (3-ISOPROPYLMALATE DEHYDROGENASE) (Salmonella enterica)	PF00180 (Iso_dh)	5	ALA A 287 ASP A 289 PRO A 298 VAL A 19 ILE A 15	None	1.17A	3oxxB-1cnzA: undetectable	3oxxB-1cnzA: 14.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1gzg	DELTA-AMINOLEVULINIC ACID DEHYDRATASE (Pseudomonas aeruginosa)	PF00490 (ALAD)	5	ASP A 249 ASP A 179 ILE A 154 VAL A 199 ILE A 182	MG A1338 ( 3.8A) None None None None	1.08A	3oxxB-1gzgA: undetectable	3oxxB-1gzgA: 14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1hqk	6,7-DIMETHYL-8-RIBIT YLLUMAZINE SYNTHASE (Aquifex aeolicus)	PF00885 (DMRL_synthase)	5	LEU A 50 ALA A 34 GLY A 114 VAL A 115 ILE A 17	None	1.29A	3oxxB-1hqkA: undetectable	3oxxB-1hqkA: 24.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1hvc	HIV-1 PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	10	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 29 ILE A 47 GLY A 49 PRO A 81 VAL A 82 ILE A 84	A79 A 800 (-3.6A) A79 A 800 ( 4.0A) A79 A 800 (-2.8A) A79 A 800 (-3.2A) A79 A 800 (-2.7A) A79 A 800 ( 3.4A) A79 A 800 (-3.4A) A79 A 800 ( 3.4A) A79 A 800 (-4.5A) A79 A 800 (-3.8A)	0.37A	3oxxB-1hvcA: 14.3	3oxxB-1hvcA: 47.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1hvc	HIV-1 PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	9	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 29 ILE A 47 GLY A 49 VAL A 82 ILE A 84	A79 A 800 (-3.4A) A79 A 800 ( 3.8A) A79 A 800 (-2.7A) A79 A 800 (-3.1A) A79 A 800 (-2.8A) A79 A 800 ( 3.2A) A79 A 800 ( 3.7A) A79 A 800 (-4.5A) A79 A 800 (-3.6A)	0.37A	3oxxB-1hvcA: 14.3	3oxxB-1hvcA: 47.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1hvc	HIV-1 PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	9	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 29 ILE A 47 PRO A 81 VAL A 82 ILE A 84	A79 A 800 (-3.4A) A79 A 800 ( 3.8A) A79 A 800 (-2.7A) A79 A 800 (-3.1A) A79 A 800 (-2.8A) A79 A 800 ( 3.2A) A79 A 800 ( 3.9A) A79 A 800 (-4.5A) A79 A 800 (-3.6A)	0.50A	3oxxB-1hvcA: 14.3	3oxxB-1hvcA: 47.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1hvc	HIV-1 PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	6	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 30 GLY A 49	A79 A 800 (-3.4A) A79 A 800 ( 3.8A) A79 A 800 (-2.7A) A79 A 800 (-3.1A) A79 A 800 ( 4.9A) A79 A 800 ( 3.7A)	1.49A	3oxxB-1hvcA: 14.3	3oxxB-1hvcA: 47.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1hvc	HIV-1 PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	6	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 30 PRO A 81	A79 A 800 (-3.4A) A79 A 800 ( 3.8A) A79 A 800 (-2.7A) A79 A 800 (-3.1A) A79 A 800 ( 4.9A) A79 A 800 ( 3.9A)	1.35A	3oxxB-1hvcA: 14.3	3oxxB-1hvcA: 47.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1hyg	L-LACTATE/MALATE DEHYDROGENASE (Methanocaldococcus jannaschii)	PF00056 (Ldh_1_N) PF02866 (Ldh_1_C)	5	ILE A 80 GLY A 83 VAL A 84 PRO A 124 VAL A 127	None NAP A 900 (-3.9A) None None None	1.23A	3oxxB-1hygA: 0.0	3oxxB-1hygA: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ion	PROBABLE CELL DIVISION INHIBITOR MIND (Pyrococcus horikoshii)	PF13614 (AAA_31)	5	ALA A 137 VAL A 233 PRO A 192 VAL A 191 ILE A 165	None	1.31A	3oxxB-1ionA: undetectable	3oxxB-1ionA: 18.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1khd	ANTHRANILATE PHOSPHORIBOSYLTRANSF ERASE (Pectobacterium carotovorum)	PF00591 (Glycos_transf_3) PF02885 (Glycos_trans_3N)	5	LEU A 249 ALA A 202 ASP A 88 GLY A 205 VAL A 206	None	1.24A	3oxxB-1khdA: 0.0	3oxxB-1khdA: 14.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1lth	L-LACTATE DEHYDROGENASE (T- AND R- STATE TETRAMER COMPLEX) (Bifidobacterium longum)	no annotation	5	ARG T 284 LEU T 252 ALA T 26 VAL T 36 ILE T 248	None	1.30A	3oxxB-1lthT: 0.0	3oxxB-1lthT: 15.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1mq0	CYTIDINE DEAMINASE (Homo sapiens)	PF00383 (dCMP_cyt_deam_1)	5	ARG A 103 GLY A 39 VAL A 38 VAL A 115 ILE A 85	None None BRD A 148 (-4.2A) None None	0.78A	3oxxB-1mq0A: undetectable	3oxxB-1mq0A: 21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1nxz	HYPOTHETICAL PROTEIN HI0303 (Haemophilus influenzae)	PF04452 (Methyltrans_RNA)	5	LEU A 40 ALA A 24 ASP A 23 ILE A 136 ILE A 6	None	1.33A	3oxxB-1nxzA: undetectable	3oxxB-1nxzA: 13.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1oxx	ABC TRANSPORTER, ATP BINDING PROTEIN (Sulfolobus solfataricus)	PF00005 (ABC_tran)	5	ALA K 208 ASP K 209 GLY K 223 VAL K 222 ILE K 204	None	1.10A	3oxxB-1oxxK: undetectable	3oxxB-1oxxK: 15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1p31	UDP-N-ACETYLMURAMATE --ALANINE LIGASE (Haemophilus influenzae)	PF01225 (Mur_ligase) PF02875 (Mur_ligase_C) PF08245 (Mur_ligase_M)	5	LEU A 111 ILE A 26 GLY A 28 VAL A 150 ILE A 34	None None EPU A 598 (-3.2A) None None	1.20A	3oxxB-1p31A: undetectable	3oxxB-1p31A: 13.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1qvz	YDR533C PROTEIN (Saccharomyces cerevisiae)	PF01965 (DJ-1_PfpI)	5	ALA A 96 ASP A 98 VAL A 48 VAL A 134 ILE A 127	None	1.23A	3oxxB-1qvzA: undetectable	3oxxB-1qvzA: 17.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1siv	SIV PROTEASE (Simian immunodeficiency virus)	PF00077 (RVP)	7	LEU A 23 ASP A 25 ALA A 28 ASP A 29 GLY A 49 PRO A 81 ILE A 84	None	0.46A	3oxxB-1sivA: 18.9	3oxxB-1sivA: 48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1t0a	2C-METHYL-D-ERYTHRIT OL 2,4-CYCLODIPHOSPHATE SYNTHASE (Shewanella oneidensis)	PF02542 (YgbB)	5	ARG A 76 LEU A 43 ASP A 97 VAL A 126 ILE A 46	None	1.12A	3oxxB-1t0aA: undetectable	3oxxB-1t0aA: 20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1tcs	TRICHOSANTHIN (Trichosanthes kirilowii)	PF00161 (RIP)	5	LEU A 215 ALA A 230 ASP A 229 VAL A 213 ILE A 225	None	1.16A	3oxxB-1tcsA: undetectable	3oxxB-1tcsA: 16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1vjv	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 6 (Saccharomyces cerevisiae)	PF00443 (UCH)	5	ARG A 316 LEU A 490 ALA A 122 ILE A 452 ILE A 436	None	1.26A	3oxxB-1vjvA: undetectable	3oxxB-1vjvA: 12.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1wx0	TRANSALDOLASE (Thermus thermophilus)	PF00923 (TAL_FSA)	5	ARG A 154 LEU A 186 ALA A 171 GLY A 140 VAL A 142	None	1.27A	3oxxB-1wx0A: undetectable	3oxxB-1wx0A: 21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1yr2	PROLYL OLIGOPEPTIDASE (Novosphingobium capsulatum)	PF00326 (Peptidase_S9) PF02897 (Peptidase_S9_N)	5	ALA A 538 ASP A 537 GLY A 529 PRO A 475 VAL A 474	None	1.08A	3oxxB-1yr2A: undetectable	3oxxB-1yr2A: 8.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2a2f	EXOCYST COMPLEX COMPONENT SEC15 (Drosophila melanogaster)	PF04091 (Sec15)	5	LEU X 239 ALA X 185 ASP X 184 GLY X 190 ILE X 242	None	0.99A	3oxxB-2a2fX: undetectable	3oxxB-2a2fX: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2aeu	HYPOTHETICAL PROTEIN MJ0158 (Methanocaldococcus jannaschii)	PF03841 (SelA)	5	LEU A 244 ASP A 207 VAL A 203 VAL A 63 ILE A 247	None SO4 A1001 (-4.0A) None None None	0.81A	3oxxB-2aeuA: undetectable	3oxxB-2aeuA: 12.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2bkl	PROLYL ENDOPEPTIDASE (Myxococcus xanthus)	PF00326 (Peptidase_S9) PF02897 (Peptidase_S9_N)	5	ALA A 496 ASP A 495 GLY A 487 PRO A 431 VAL A 430	None	1.11A	3oxxB-2bklA: undetectable	3oxxB-2bklA: 10.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2cun	PHOSPHOGLYCERATE KINASE (Pyrococcus horikoshii)	PF00162 (PGK)	5	LEU A 316 ILE A 376 GLY A 357 VAL A 343 ILE A 347	None	0.93A	3oxxB-2cunA: undetectable	3oxxB-2cunA: 13.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2fmb	EQUINE INFECTIOUS ANEMIA VIRUS PROTEASE (Equine infectious anemia virus)	PF00077 (RVP)	11	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 29 ILE A 53 GLY A 55 VAL A 56 PRO A 86 VAL A 87 ILE A 89	LP1 A 201 (-3.5A) None LP1 A 201 (-2.3A) LP1 A 201 (-3.5A) LP1 A 201 (-3.6A) LP1 A 201 (-4.6A) LP1 A 201 (-3.4A) LP1 A 201 ( 4.7A) LP1 A 201 (-3.9A) LP1 A 201 ( 4.9A) LP1 A 201 (-4.2A)	0.51A	3oxxB-2fmbA: 15.4	3oxxB-2fmbA: 37.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2fr5	CYTIDINE DEAMINASE (Mus musculus)	PF00383 (dCMP_cyt_deam_1)	5	ARG A 103 GLY A 39 VAL A 38 VAL A 115 ILE A 85	None None TYU A1001 (-4.1A) None None	0.75A	3oxxB-2fr5A: undetectable	3oxxB-2fr5A: 19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2g0f	THIOL:DISULFIDE INTERCHANGE PROTEIN DSBE (Escherichia coli)	PF08534 (Redoxin)	5	GLY A 139 VAL A 140 PRO A 46 VAL A 45 ILE A 155	None	1.11A	3oxxB-2g0fA: undetectable	3oxxB-2g0fA: 18.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2gwn	DIHYDROOROTASE (Porphyromonas gingivalis)	PF01979 (Amidohydro_1)	5	ALA A 121 ILE A 60 GLY A 58 VAL A 386 VAL A 336	None	1.25A	3oxxB-2gwnA: undetectable	3oxxB-2gwnA: 14.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2h88	SUCCINATE DEHYDROGENASE FLAVOPROTEIN SUBUNIT (Gallus gallus)	PF00890 (FAD_binding_2) PF02910 (Succ_DH_flav_C)	5	ARG A 269 LEU A 323 ASP A 351 VAL A 359 ILE A 357	None	1.27A	3oxxB-2h88A: undetectable	3oxxB-2h88A: 9.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2hzg	MANDELATE RACEMASE/MUCONATE LACTONIZING ENZYME/ENOLASE SUPERFAMILY (Rhodobacter sphaeroides)	PF02746 (MR_MLE_N) PF13378 (MR_MLE_C)	5	LEU A 310 ALA A 28 ASP A 27 VAL A 366 ILE A 341	None	0.97A	3oxxB-2hzgA: undetectable	3oxxB-2hzgA: 12.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2hzk	TRAP-T FAMILY SORBITOL/MANNITOL TRANSPORTER, PERIPLASMIC BINDING PROTEIN, SMOM (Rhodobacter sphaeroides)	PF03480 (DctP)	5	ALA A 147 GLY A 98 VAL A 97 VAL A 86 ILE A 145	None	1.24A	3oxxB-2hzkA: undetectable	3oxxB-2hzkA: 13.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2rkf	PROTEASE RETROPEPSIN (Human immunodeficiency virus 1)	PF00077 (RVP)	8	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 29 GLY A 49 PRO A 81 ILE A 84	AB1 A 501 ( 4.7A) None AB1 A 501 (-2.4A) AB1 A 501 (-3.5A) AB1 A 501 ( 3.3A) AB1 A 501 (-3.5A) AB1 A 501 (-4.2A) AB1 A 501 ( 4.2A)	0.32A	3oxxB-2rkfA: 20.8	3oxxB-2rkfA: 83.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2rsp	RSV PROTEASE (Rous sarcoma virus)	PF00077 (RVP)	5	ARG A 10 LEU A 35 ASP A 37 ALA A 40 ASP A 41	None	0.84A	3oxxB-2rspA: 13.2	3oxxB-2rspA: 32.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2rsp	RSV PROTEASE (Rous sarcoma virus)	PF00077 (RVP)	6	ARG A 105 LEU A 35 ASP A 37 ALA A 40 ASP A 41 ILE A 108	None	1.47A	3oxxB-2rspA: 13.2	3oxxB-2rspA: 32.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2v3c	SIGNAL RECOGNITION 54 KDA PROTEIN (Methanocaldococcus jannaschii)	PF00448 (SRP54) PF02881 (SRP54_N) PF02978 (SRP_SPB)	5	ALA C 136 ASP C 137 PRO C 212 VAL C 102 ILE C 187	None	1.34A	3oxxB-2v3cC: undetectable	3oxxB-2v3cC: 13.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2vz9	FATTY ACID SYNTHASE (Sus scrofa)	PF00107 (ADH_zinc_N) PF00109 (ketoacyl-synt) PF00698 (Acyl_transf_1) PF02801 (Ketoacyl-synt_C) PF08242 (Methyltransf_12) PF08659 (KR) PF14765 (PS-DH) PF16197 (KAsynt_C_assoc)	5	LEU A 567 ALA A 590 ASP A 591 GLY A 579 ILE A 564	None	1.23A	3oxxB-2vz9A: undetectable	3oxxB-2vz9A: 3.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2wdw	PUTATIVE HEXOSE OXIDASE (Nonomuraea gerenzanensis)	PF01565 (FAD_binding_4) PF08031 (BBE)	5	ALA A 73 ASP A 72 VAL A 187 VAL A 86 ILE A 106	None None None FAD A 601 (-4.2A) None	1.21A	3oxxB-2wdwA: undetectable	3oxxB-2wdwA: 15.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2wu5	SUCCINATE DEHYDROGENASE FLAVOPROTEIN SUBUNIT (Escherichia coli)	PF00890 (FAD_binding_2) PF02910 (Succ_DH_flav_C)	5	ARG A 258 LEU A 313 ASP A 341 VAL A 349 ILE A 347	None	1.12A	3oxxB-2wu5A: undetectable	3oxxB-2wu5A: 10.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2xua	3-OXOADIPATE ENOL-LACTONASE (Paraburkholderia xenovorans)	PF12146 (Hydrolase_4)	5	ARG A 61 LEU A 78 ALA A 196 ASP A 197 ILE A 75	None	1.23A	3oxxB-2xuaA: undetectable	3oxxB-2xuaA: 17.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2zc8	N-ACYLAMINO ACID RACEMASE (Thermus thermophilus)	PF02746 (MR_MLE_N) PF13378 (MR_MLE_C)	5	ARG A 35 LEU A 351 ALA A 294 VAL A 356 ILE A 327	None	1.27A	3oxxB-2zc8A: undetectable	3oxxB-2zc8A: 14.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3a31	PROBABLE THREONYL-TRNA SYNTHETASE 1 (Aeropyrum pernix)	PF00587 (tRNA-synt_2b) PF03129 (HGTP_anticodon)	5	ALA A 438 ASP A 437 VAL A 445 VAL A 343 ILE A 363	None	1.12A	3oxxB-3a31A: undetectable	3oxxB-3a31A: 12.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3dmo	CYTIDINE DEAMINASE (Burkholderia pseudomallei)	PF00383 (dCMP_cyt_deam_1)	5	ARG A 92 GLY A 27 VAL A 26 VAL A 105 ILE A 75	None	0.96A	3oxxB-3dmoA: undetectable	3oxxB-3dmoA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3gs9	PROTEIN GP18 (Listeria monocytogenes)	PF06605 (Prophage_tail)	5	LEU A 157 ASP A 154 PRO A 166 VAL A 164 ILE A 153	None	1.30A	3oxxB-3gs9A: undetectable	3oxxB-3gs9A: 14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3gt7	SENSOR PROTEIN (Syntrophus aciditrophicus)	PF00072 (Response_reg)	5	ARG A 102 ALA A 108 ASP A 109 ILE A 59 VAL A 63	None	1.11A	3oxxB-3gt7A: undetectable	3oxxB-3gt7A: 23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3il2	REDOX-SENSING TRANSCRIPTIONAL REPRESSOR REX (Thermus thermophilus)	PF02629 (CoA_binding) PF06971 (Put_DNA-bind_N)	5	LEU A 145 ALA A 96 ILE A 127 GLY A 125 ILE A 85	None	1.31A	3oxxB-3il2A: undetectable	3oxxB-3il2A: 23.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3it4	ARGININE BIOSYNTHESIS BIFUNCTIONAL PROTEIN ARGJ ALPHA CHAIN ARGININE BIOSYNTHESIS BIFUNCTIONAL PROTEIN ARGJ BETA CHAIN (Mycobacterium tuberculosis)	PF01960 (ArgJ)	5	ASP B 241 ILE A 130 GLY A 128 PRO A 64 VAL A 65	None	0.97A	3oxxB-3it4B: undetectable	3oxxB-3it4B: 19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3l2z	BIRA BIFUNCTIONAL PROTEIN (Mycobacterium tuberculosis)	PF02237 (BPL_C) PF03099 (BPL_LplA_LipB)	5	ARG A 189 LEU A 116 ASP A 175 VAL A 132 ILE A 117	None	1.23A	3oxxB-3l2zA: undetectable	3oxxB-3l2zA: 18.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3mws	HIV-1 PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	9	LEU A 23 ASP A 25 ALA A 28 ASP A 29 ILE A 47 GLY A 49 PRO A 81 VAL A 82 ILE A 84	None	0.41A	3oxxB-3mwsA: 19.9	3oxxB-3mwsA: 74.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3n0w	ABC BRANCHED CHAIN AMINO ACID FAMILY TRANSPORTER, PERIPLASMIC LIGAND BINDING PROTEIN (Paraburkholderia xenovorans)	PF13458 (Peripla_BP_6)	5	ARG A 86 LEU A 112 ALA A 120 GLY A 30 ILE A 109	None	1.14A	3oxxB-3n0wA: undetectable	3oxxB-3n0wA: 14.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3pdi	NITROGENASE MOFE COFACTOR BIOSYNTHESIS PROTEIN NIFE (Azotobacter vinelandii)	PF00148 (Oxidored_nitro)	5	ASP A 131 ALA A 98 ASP A 92 ILE A 94 ILE A 129	None	1.13A	3oxxB-3pdiA: undetectable	3oxxB-3pdiA: 11.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3s1s	RESTRICTION ENDONUCLEASE BPUSI (Bacillus pumilus)	PF02384 (N6_Mtase) PF15516 (BpuSI_N)	5	LEU A 361 ASP A 327 ILE A 351 VAL A 243 ILE A 384	None None None EDO A 913 (-3.8A) EDO A 913 (-4.2A)	1.36A	3oxxB-3s1sA: undetectable	3oxxB-3s1sA: 7.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3t3c	HIV-1 PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	7	LEU A 23 ASP A 25 ALA A 28 ASP A 29 ILE A 47 GLY A 49 PRO A 81	SO4 A 101 (-4.2A) 017 A 201 (-2.6A) 017 A 201 (-3.5A) 017 A 201 (-3.5A) None 017 A 201 (-4.0A) None	0.70A	3oxxB-3t3cA: 18.6	3oxxB-3t3cA: 74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3t3c	HIV-1 PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	5	LEU A 23 ASP A 25 ALA A 28 ASP A 30 GLY A 49	SO4 A 101 (-4.2A) 017 A 201 (-2.6A) 017 A 201 (-3.5A) 017 A 201 (-4.2A) 017 A 201 (-4.0A)	1.25A	3oxxB-3t3cA: 18.6	3oxxB-3t3cA: 74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ttp	HIV-1 PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	7	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 29 GLY A 49 PRO A 81	017 A 201 ( 4.8A) None 017 A 201 (-2.6A) 017 A 201 (-3.4A) 017 A 201 (-3.3A) 017 A 201 (-3.0A) 017 A 201 (-4.1A)	0.45A	3oxxB-3ttpA: 19.9	3oxxB-3ttpA: 78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ttp	HIV-1 PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	7	LEU A 23 ASP A 25 ALA A 28 ASP A 29 GLY A 49 PRO A 81 ILE A 84	None 017 A 201 (-2.6A) 017 A 201 (-3.4A) 017 A 201 (-3.3A) 017 A 201 (-3.0A) 017 A 201 (-4.1A) 017 A 201 (-4.7A)	0.31A	3oxxB-3ttpA: 19.9	3oxxB-3ttpA: 78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3u7s	POL POLYPROTEIN (Human immunodeficiency virus 1)	PF00077 (RVP)	8	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 29 ILE A 47 GLY A 49 PRO A 81	None None 017 A 202 ( 2.5A) 017 A 201 (-3.4A) 017 A 201 (-3.2A) 017 A 202 (-3.6A) 017 A 202 (-2.9A) 017 A 202 (-4.0A)	0.46A	3oxxB-3u7sA: 20.1	3oxxB-3u7sA: 77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3u7s	POL POLYPROTEIN (Human immunodeficiency virus 1)	PF00077 (RVP)	6	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 30 GLY A 49	None None 017 A 202 ( 2.5A) 017 A 201 (-3.4A) 017 A 201 ( 4.0A) 017 A 202 (-2.9A)	1.44A	3oxxB-3u7sA: 20.1	3oxxB-3u7sA: 77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3uhl	PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	6	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 29 VAL A 82	None	0.70A	3oxxB-3uhlA: 16.1	3oxxB-3uhlA: 77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3uhl	PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	6	LEU A 23 ASP A 25 ALA A 28 ASP A 29 PRO A 81 VAL A 82	None	0.54A	3oxxB-3uhlA: 16.1	3oxxB-3uhlA: 77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3vrb	FLAVOPROTEIN SUBUNIT OF COMPLEX II (Ascaris suum)	PF00890 (FAD_binding_2) PF02910 (Succ_DH_flav_C)	5	ARG A 292 LEU A 346 ASP A 374 VAL A 382 ILE A 380	None	1.11A	3oxxB-3vrbA: undetectable	3oxxB-3vrbA: 9.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3zpc	RIBOFLAVIN BIOSYNTHESIS PROTEIN RIBD (Acinetobacter baumannii)	PF00383 (dCMP_cyt_deam_1) PF01872 (RibD_C)	5	LEU A 242 ASP A 204 GLY A 197 VAL A 248 ILE A 241	None	0.88A	3oxxB-3zpcA: undetectable	3oxxB-3zpcA: 15.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4axv	MPAA (Vibrio campbellii)	PF04952 (AstE_AspA)	5	LEU A 174 ALA A 225 ASP A 224 GLY A 57 VAL A 208	None	1.00A	3oxxB-4axvA: undetectable	3oxxB-4axvA: 16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4dr9	PEPTIDE DEFORMYLASE (Synechococcus elongatus)	PF01327 (Pep_deformylase)	5	LEU A 51 ASP A 41 ILE A 39 VAL A 75 ILE A 47	None	1.18A	3oxxB-4dr9A: undetectable	3oxxB-4dr9A: 19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4e4j	ARGININE DEIMINASE (Mycoplasma penetrans)	PF02274 (Amidinotransf)	5	LEU A 109 GLY A 62 PRO A 444 VAL A 67 ILE A 114	None	1.00A	3oxxB-4e4jA: undetectable	3oxxB-4e4jA: 12.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4fe9	OUTER MEMBRANE PROTEIN SUSF (Bacteroides thetaiotaomicron)	PF16411 (SusF_SusE) PF17142 (DUF5115)	5	LEU A 387 ILE A 453 GLY A 482 VAL A 427 ILE A 429	None	1.14A	3oxxB-4fe9A: undetectable	3oxxB-4fe9A: 14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4g1g	MATRIX PROTEIN (Avian avulavirus 1)	PF00661 (Matrix)	5	LEU A 322 ALA A 320 ILE A 314 VAL A 208 ILE A 210	None	0.99A	3oxxB-4g1gA: undetectable	3oxxB-4g1gA: 14.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4j5u	SERINE HYDROXYMETHYLTRANSFE RASE (Rickettsia rickettsii)	PF00464 (SHMT)	5	ALA A 333 ASP A 337 ILE A 341 VAL A 320 ILE A 361	None	1.32A	3oxxB-4j5uA: undetectable	3oxxB-4j5uA: 14.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4lcb	CELL DIVISION PROTEIN CDVC, VPS4 (Acidianus hospitalis)	PF00004 (AAA) PF09336 (Vps4_C)	5	LEU A 133 ALA A 108 PRO A 265 VAL A 264 ILE A 262	None	1.21A	3oxxB-4lcbA: undetectable	3oxxB-4lcbA: 13.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4lhu	9C2 TCR DELTA CHAIN (Homo sapiens)	PF07654 (C1-set) PF07686 (V-set)	5	LEU D 84 ASP D 88 ILE D 52 GLY D 64 ILE D 81	None	1.30A	3oxxB-4lhuD: undetectable	3oxxB-4lhuD: 18.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4njv	PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	9	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 29 ILE A 47 GLY A 49 PRO A 81 ILE A 84	RIT A 500 (-3.2A) None RIT A 500 (-2.4A) RIT A 500 (-3.6A) RIT A 500 (-3.2A) RIT A 500 ( 4.5A) RIT A 500 (-3.4A) RIT A 500 (-3.9A) RIT A 500 (-4.3A)	0.36A	3oxxB-4njvA: 20.8	3oxxB-4njvA: 84.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ox8	CARBON DIOXIDE-CONCENTRATIN G MECHANISM PROTEIN CCMK (Prochlorococcus marinus)	PF00936 (BMC)	5	ALA A 66 GLY A 75 VAL A 72 VAL A 49 ILE A 13	None	1.05A	3oxxB-4ox8A: undetectable	3oxxB-4ox8A: 19.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4pxn	UNCHARACTERIZED PROTEIN (Zea mays)	PF00171 (Aldedh)	5	LEU A 307 ALA A 292 ILE A 455 VAL A 276 ILE A 274	None	1.03A	3oxxB-4pxnA: undetectable	3oxxB-4pxnA: 11.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4qfb	CT263 (Chlamydia trachomatis)	no annotation	5	LEU A 18 ALA A 183 ILE A 156 GLY A 71 VAL A 42	None	1.27A	3oxxB-4qfbA: undetectable	3oxxB-4qfbA: 15.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4r37	PUTATIVE ACYL-[ACYL-CARRIER-P ROTEIN]--UDP-N-ACETY LGLUCOSAMINE O-ACYLTRANSFERASE (Bacteroides fragilis)	PF00132 (Hexapep) PF13720 (Acetyltransf_11)	5	LEU A 110 ALA A 60 ILE A 44 GLY A 63 ILE A 86	None	0.98A	3oxxB-4r37A: undetectable	3oxxB-4r37A: 21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4tqv	ALGM1 ALGM2 (Sphingomonas sp.)	PF00528 (BPD_transp_1)	5	ILE A 147 GLY A 150 VAL A 153 VAL B 259 ILE B 263	None	1.14A	3oxxB-4tqvA: undetectable	3oxxB-4tqvA: 14.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ydf	HTLV-1 PROTEASE (Primate T-lymphotropic virus 1)	PF00077 (RVP)	7	ARG A 10 LEU A 30 ASP A 32 ALA A 35 ASP A 36 GLY A 58 ILE A 100	None None 4B1 A 201 (-2.9A) 4B1 A 201 (-3.6A) 4B1 A 201 (-4.4A) 4B1 A 201 (-3.4A) 4B1 A 201 (-4.8A)	0.55A	3oxxB-4ydfA: 13.1	3oxxB-4ydfA: 33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4zqi	D-ALANINE--D-ALANINE LIGASE (Yersinia pestis)	PF01820 (Dala_Dala_lig_N) PF07478 (Dala_Dala_lig_C)	5	LEU A 8 GLY A 87 VAL A 88 VAL A 58 ILE A 60	None	1.02A	3oxxB-4zqiA: undetectable	3oxxB-4zqiA: 16.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5b18	PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	5	ALA A 28 ASP A 29 GLY A 49 VAL A 50 ILE A 84	None	0.84A	3oxxB-5b18A: 18.3	3oxxB-5b18A: 76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5b18	PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	5	ALA A 28 ASP A 29 VAL A 50 PRO A 81 ILE A 84	None	1.29A	3oxxB-5b18A: 18.3	3oxxB-5b18A: 76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5b18	PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	5	ARG A 8 ALA A 28 ASP A 29 GLY A 49 ILE A 84	None	0.81A	3oxxB-5b18A: 18.3	3oxxB-5b18A: 76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5b18	PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	5	ARG A 8 ALA A 28 ASP A 29 PRO A 81 ILE A 84	None	0.52A	3oxxB-5b18A: 18.3	3oxxB-5b18A: 76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5brq	GLYCOSIDE HYDROLASE FAMILY 13 (Bacillus licheniformis)	PF00128 (Alpha-amylase) PF16657 (Malt_amylase_C)	5	ASP A 83 ILE A 36 GLY A 31 VAL A 30 ILE A 56	None None MG A 601 ( 4.6A) MG A 601 (-4.8A) None	0.92A	3oxxB-5brqA: undetectable	3oxxB-5brqA: 10.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5hm7	BUTYROPHILIN SUBFAMILY 3 MEMBER A1 (Homo sapiens)	PF00622 (SPRY) PF13765 (PRY)	5	LEU A 434 ALA A 310 ASP A 311 ILE A 480 VAL A 381	None	1.28A	3oxxB-5hm7A: undetectable	3oxxB-5hm7A: 14.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5j32	3-ISOPROPYLMALATE DEHYDROGENASE 2, CHLOROPLASTIC (Arabidopsis thaliana)	PF00180 (Iso_dh)	5	ALA A 324 ASP A 326 PRO A 335 VAL A 57 ILE A 53	None	1.34A	3oxxB-5j32A: undetectable	3oxxB-5j32A: 14.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5lyk	BUTYROPHILIN SUBFAMILY 3 MEMBER A1 (Homo sapiens)	PF00622 (SPRY) PF13765 (PRY)	5	LEU A 464 ALA A 340 ASP A 341 ILE A 510 VAL A 411	None	1.34A	3oxxB-5lykA: undetectable	3oxxB-5lykA: 15.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5m72	SIGNAL RECOGNITION PARTICLE SUBUNIT SRP72 (Homo sapiens)	PF17004 (SRP_TPR_like)	5	ASP A 44 ALA A 47 PRO A 12 VAL A 11 ILE A 37	None	1.11A	3oxxB-5m72A: undetectable	3oxxB-5m72A: 20.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5t2z	PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	9	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 29 ILE A 47 GLY A 49 PRO A 81 ILE A 84	None	0.37A	3oxxB-5t2zA: 20.0	3oxxB-5t2zA: 77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5t2z	PROTEASE (Human immunodeficiency virus 1)	PF00077 (RVP)	6	ARG A 8 LEU A 23 ASP A 25 ALA A 28 ASP A 30 GLY A 49	None	1.47A	3oxxB-5t2zA: 20.0	3oxxB-5t2zA: 77.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5wxv	ISOCHORISMATE LYASE (Vibrio anguillarum)	no annotation	5	LEU A 59 ALA A 178 ASP A 179 GLY A 174 VAL A 173	None	1.13A	3oxxB-5wxvA: undetectable	3oxxB-5wxvA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5y0q	UPF0348 PROTEIN B4417_3650 (Bacillus subtilis)	no annotation	5	LEU A 70 ALA A 332 VAL A 360 VAL A 36 ILE A 89	None	1.24A	3oxxB-5y0qA: undetectable	3oxxB-5y0qA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6c0d	AMIDASE, HYDANTOINASE/CARBAMO YLASE FAMILY (Paraburkholderia phymatum)	no annotation	5	ALA A 342 ASP A 343 PRO A 376 VAL A 375 ILE A 202	None SO4 A 504 (-4.1A) EDO A 509 ( 4.5A) None None	1.23A	3oxxB-6c0dA: undetectable	3oxxB-6c0dA: 20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6cc2	CELL DIVISION CONTROL PROTEIN 45 CDC45 PUTATIVE (Entamoeba histolytica)	no annotation	5	ALA A 357 ILE A 213 GLY A 362 VAL A 37 ILE A 206	None	1.13A	3oxxB-6cc2A: undetectable	3oxxB-6cc2A: 21.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6fiv	RETROPEPSIN (Feline immunodeficiency virus)	PF00077 (RVP)	7	ARG A 13 LEU A 28 ASP A 30 ALA A 33 ASP A 34 GLY A 58 VAL A 59	None None 3TL A 201 (-3.5A) 3TL A 201 (-4.0A) 3TL A 201 (-3.9A) 3TL A 201 (-3.4A) 3TL A 201 (-4.3A)	0.38A	3oxxB-6fivA: 15.4	3oxxB-6fivA: 30.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6fiv	RETROPEPSIN (Feline immunodeficiency virus)	PF00077 (RVP)	7	ARG A 13 LEU A 28 ASP A 30 ALA A 33 ASP A 34 VAL A 59 VAL A 99	None None 3TL A 201 (-3.5A) 3TL A 201 (-4.0A) 3TL A 201 (-3.9A) 3TL A 201 (-4.3A) None	0.56A	3oxxB-6fivA: 15.4	3oxxB-6fivA: 30.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6upj	HIV-2 PROTEASE (Human immunodeficiency virus 2)	PF00077 (RVP)	7	LEU A 23 ASP A 25 ALA A 28 ASP A 29 GLY A 49 PRO A 81 ILE A 84	None NIU A 100 (-2.8A) NIU A 100 (-3.6A) None NIU A 100 ( 3.8A) None None	0.65A	3oxxB-6upjA: 18.2	3oxxB-6upjA: 48.48

[["3OXX_A_DR7A100_2","1a6d","Thermoplasma acidophilum","THERMOSOME (BETA SUBUNIT)","PF00118(Cpn60_TCP1)",5,"LEU B 449;ALA B 413;GLY B 499;VAL B 498;ILE B 445","None","1.12A","3oxxB-1a6dB:undetectable","3oxxB-1a6dB:12.84"],["3OXX_A_DR7A100_2","1bl5","Escherichia coli","ISOCITRATE DEHYDROGENASE","PF00180(Iso_dh)",5,"LEU A 290;ALA A 312;ASP A 311;GLY A 319;PRO A 144","None;None; MG A 418 ( 3.9A);None;None","1.24A","3oxxB-1bl5A:0.0","3oxxB-1bl5A:13.45"],["3OXX_A_DR7A100_2","1cnz","Salmonella enterica","PROTEIN (3-ISOPROPYLMALATE DEHYDROGENASE)","PF00180(Iso_dh)",5,"ALA A 287;ASP A 289;PRO A 298;VAL A  19;ILE A  15","None","1.17A","3oxxB-1cnzA:undetectable","3oxxB-1cnzA:14.47"],["3OXX_A_DR7A100_2","1gzg","Pseudomonas aeruginosa","DELTA-AMINOLEVULINIC ACID DEHYDRATASE","PF00490(ALAD)",5,"ASP A 249;ASP A 179;ILE A 154;VAL A 199;ILE A 182"," MG A1338 ( 3.8A);None;None;None;None","1.08A","3oxxB-1gzgA:undetectable","3oxxB-1gzgA:14.33"],["3OXX_A_DR7A100_2","1hqk","Aquifex aeolicus","6,7-DIMETHYL-8-RIBITYLLUMAZINE SYNTHASE","PF00885(DMRL_synthase)",5,"LEU A  50;ALA A  34;GLY A 114;VAL A 115;ILE A  17","None","1.29A","3oxxB-1hqkA:undetectable","3oxxB-1hqkA:24.00"],["3OXX_A_DR7A100_2","1hvc","Human immunodeficiency virus 1","HIV-1 PROTEASE","PF00077(RVP)",10,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  29;ILE A  47;GLY A  49;PRO A  81;VAL A  82;ILE A  84","A79 A 800 (-3.6A);A79 A 800 ( 4.0A);A79 A 800 (-2.8A);A79 A 800 (-3.2A);A79 A 800 (-2.7A);A79 A 800 ( 3.4A);A79 A 800 (-3.4A);A79 A 800 ( 3.4A);A79 A 800 (-4.5A);A79 A 800 (-3.8A)","0.37A","3oxxB-1hvcA:14.3","3oxxB-1hvcA:47.29"],["3OXX_A_DR7A100_2","1hvc","Human immunodeficiency virus 1","HIV-1 PROTEASE","PF00077(RVP)",9,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  29;ILE A  47;GLY A  49;VAL A  82;ILE A  84","A79 A 800 (-3.4A);A79 A 800 ( 3.8A);A79 A 800 (-2.7A);A79 A 800 (-3.1A);A79 A 800 (-2.8A);A79 A 800 ( 3.2A);A79 A 800 ( 3.7A);A79 A 800 (-4.5A);A79 A 800 (-3.6A)","0.37A","3oxxB-1hvcA:14.3","3oxxB-1hvcA:47.29"],["3OXX_A_DR7A100_2","1hvc","Human immunodeficiency virus 1","HIV-1 PROTEASE","PF00077(RVP)",9,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  29;ILE A  47;PRO A  81;VAL A  82;ILE A  84","A79 A 800 (-3.4A);A79 A 800 ( 3.8A);A79 A 800 (-2.7A);A79 A 800 (-3.1A);A79 A 800 (-2.8A);A79 A 800 ( 3.2A);A79 A 800 ( 3.9A);A79 A 800 (-4.5A);A79 A 800 (-3.6A)","0.50A","3oxxB-1hvcA:14.3","3oxxB-1hvcA:47.29"],["3OXX_A_DR7A100_2","1hvc","Human immunodeficiency virus 1","HIV-1 PROTEASE","PF00077(RVP)",6,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  30;GLY A  49","A79 A 800 (-3.4A);A79 A 800 ( 3.8A);A79 A 800 (-2.7A);A79 A 800 (-3.1A);A79 A 800 ( 4.9A);A79 A 800 ( 3.7A)","1.49A","3oxxB-1hvcA:14.3","3oxxB-1hvcA:47.29"],["3OXX_A_DR7A100_2","1hvc","Human immunodeficiency virus 1","HIV-1 PROTEASE","PF00077(RVP)",6,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  30;PRO A  81","A79 A 800 (-3.4A);A79 A 800 ( 3.8A);A79 A 800 (-2.7A);A79 A 800 (-3.1A);A79 A 800 ( 4.9A);A79 A 800 ( 3.9A)","1.35A","3oxxB-1hvcA:14.3","3oxxB-1hvcA:47.29"],["3OXX_A_DR7A100_2","1hyg","Methanocaldococcus jannaschii","L-LACTATE\/MALATE DEHYDROGENASE","PF00056(Ldh_1_N);PF02866(Ldh_1_C)",5,"ILE A  80;GLY A  83;VAL A  84;PRO A 124;VAL A 127","None;NAP A 900 (-3.9A);None;None;None","1.23A","3oxxB-1hygA:0.0","3oxxB-1hygA:14.70"],["3OXX_A_DR7A100_2","1ion","Pyrococcus horikoshii","PROBABLE CELL DIVISION INHIBITOR MIND","PF13614(AAA_31)",5,"ALA A 137;VAL A 233;PRO A 192;VAL A 191;ILE A 165","None","1.31A","3oxxB-1ionA:undetectable","3oxxB-1ionA:18.03"],["3OXX_A_DR7A100_2","1khd","Pectobacterium carotovorum","ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE","PF00591(Glycos_transf_3);PF02885(Glycos_trans_3N)",5,"LEU A 249;ALA A 202;ASP A  88;GLY A 205;VAL A 206","None","1.24A","3oxxB-1khdA:0.0","3oxxB-1khdA:14.93"],["3OXX_A_DR7A100_2","1lth","Bifidobacterium longum","L-LACTATE DEHYDROGENASE (T- AND R- STATE TETRAMER COMPLEX)","no annotation",5,"ARG T 284;LEU T 252;ALA T  26;VAL T  36;ILE T 248","None","1.30A","3oxxB-1lthT:0.0","3oxxB-1lthT:15.99"],["3OXX_A_DR7A100_2","1mq0","Homo sapiens","CYTIDINE DEAMINASE","PF00383(dCMP_cyt_deam_1)",5,"ARG A 103;GLY A  39;VAL A  38;VAL A 115;ILE A  85","None;None;BRD A 148 (-4.2A);None;None","0.78A","3oxxB-1mq0A:undetectable","3oxxB-1mq0A:21.90"],["3OXX_A_DR7A100_2","1nxz","Haemophilus influenzae","HYPOTHETICAL PROTEIN HI0303","PF04452(Methyltrans_RNA)",5,"LEU A  40;ALA A  24;ASP A  23;ILE A 136;ILE A   6","None","1.33A","3oxxB-1nxzA:undetectable","3oxxB-1nxzA:13.82"],["3OXX_A_DR7A100_2","1oxx","Sulfolobus solfataricus","ABC TRANSPORTER, ATP BINDING PROTEIN","PF00005(ABC_tran)",5,"ALA K 208;ASP K 209;GLY K 223;VAL K 222;ILE K 204","None","1.10A","3oxxB-1oxxK:undetectable","3oxxB-1oxxK:15.14"],["3OXX_A_DR7A100_2","1p31","Haemophilus influenzae","UDP-N-ACETYLMURAMATE--ALANINE LIGASE","PF01225(Mur_ligase);PF02875(Mur_ligase_C);PF08245(Mur_ligase_M)",5,"LEU A 111;ILE A  26;GLY A  28;VAL A 150;ILE A  34","None;None;EPU A 598 (-3.2A);None;None","1.20A","3oxxB-1p31A:undetectable","3oxxB-1p31A:13.73"],["3OXX_A_DR7A100_2","1qvz","Saccharomyces cerevisiae","YDR533C PROTEIN","PF01965(DJ-1_PfpI)",5,"ALA A  96;ASP A  98;VAL A  48;VAL A 134;ILE A 127","None","1.23A","3oxxB-1qvzA:undetectable","3oxxB-1qvzA:17.80"],["3OXX_A_DR7A100_2","1siv","Simian immunodeficiency virus","SIV PROTEASE","PF00077(RVP)",7,"LEU A  23;ASP A  25;ALA A  28;ASP A  29;GLY A  49;PRO A  81;ILE A  84","None","0.46A","3oxxB-1sivA:18.9","3oxxB-1sivA:48.48"],["3OXX_A_DR7A100_2","1t0a","Shewanella oneidensis","2C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","PF02542(YgbB)",5,"ARG A  76;LEU A  43;ASP A  97;VAL A 126;ILE A  46","None","1.12A","3oxxB-1t0aA:undetectable","3oxxB-1t0aA:20.13"],["3OXX_A_DR7A100_2","1tcs","Trichosanthes kirilowii","TRICHOSANTHIN","PF00161(RIP)",5,"LEU A 215;ALA A 230;ASP A 229;VAL A 213;ILE A 225","None","1.16A","3oxxB-1tcsA:undetectable","3oxxB-1tcsA:16.87"],["3OXX_A_DR7A100_2","1vjv","Saccharomyces cerevisiae","UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 6","PF00443(UCH)",5,"ARG A 316;LEU A 490;ALA A 122;ILE A 452;ILE A 436","None","1.26A","3oxxB-1vjvA:undetectable","3oxxB-1vjvA:12.97"],["3OXX_A_DR7A100_2","1wx0","Thermus thermophilus","TRANSALDOLASE","PF00923(TAL_FSA)",5,"ARG A 154;LEU A 186;ALA A 171;GLY A 140;VAL A 142","None","1.27A","3oxxB-1wx0A:undetectable","3oxxB-1wx0A:21.46"],["3OXX_A_DR7A100_2","1yr2","Novosphingobium capsulatum","PROLYL OLIGOPEPTIDASE","PF00326(Peptidase_S9);PF02897(Peptidase_S9_N)",5,"ALA A 538;ASP A 537;GLY A 529;PRO A 475;VAL A 474","None","1.08A","3oxxB-1yr2A:undetectable","3oxxB-1yr2A:8.60"],["3OXX_A_DR7A100_2","2a2f","Drosophila melanogaster","EXOCYST COMPLEX COMPONENT SEC15","PF04091(Sec15)",5,"LEU X 239;ALA X 185;ASP X 184;GLY X 190;ILE X 242","None","0.99A","3oxxB-2a2fX:undetectable","3oxxB-2a2fX:14.29"],["3OXX_A_DR7A100_2","2aeu","Methanocaldococcus jannaschii","HYPOTHETICAL PROTEIN MJ0158","PF03841(SelA)",5,"LEU A 244;ASP A 207;VAL A 203;VAL A  63;ILE A 247","None;SO4 A1001 (-4.0A);None;None;None","0.81A","3oxxB-2aeuA:undetectable","3oxxB-2aeuA:12.27"],["3OXX_A_DR7A100_2","2bkl","Myxococcus xanthus","PROLYL ENDOPEPTIDASE","PF00326(Peptidase_S9);PF02897(Peptidase_S9_N)",5,"ALA A 496;ASP A 495;GLY A 487;PRO A 431;VAL A 430","None","1.11A","3oxxB-2bklA:undetectable","3oxxB-2bklA:10.79"],["3OXX_A_DR7A100_2","2cun","Pyrococcus horikoshii","PHOSPHOGLYCERATE KINASE","PF00162(PGK)",5,"LEU A 316;ILE A 376;GLY A 357;VAL A 343;ILE A 347","None","0.93A","3oxxB-2cunA:undetectable","3oxxB-2cunA:13.09"],["3OXX_A_DR7A100_2","2fmb","Equine infectious anemia virus","EQUINE INFECTIOUS ANEMIA VIRUS PROTEASE","PF00077(RVP)",11,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  29;ILE A  53;GLY A  55;VAL A  56;PRO A  86;VAL A  87;ILE A  89","LP1 A 201 (-3.5A);None;LP1 A 201 (-2.3A);LP1 A 201 (-3.5A);LP1 A 201 (-3.6A);LP1 A 201 (-4.6A);LP1 A 201 (-3.4A);LP1 A 201 ( 4.7A);LP1 A 201 (-3.9A);LP1 A 201 ( 4.9A);LP1 A 201 (-4.2A)","0.51A","3oxxB-2fmbA:15.4","3oxxB-2fmbA:37.38"],["3OXX_A_DR7A100_2","2fr5","Mus musculus","CYTIDINE DEAMINASE","PF00383(dCMP_cyt_deam_1)",5,"ARG A 103;GLY A  39;VAL A  38;VAL A 115;ILE A  85","None;None;TYU A1001 (-4.1A);None;None","0.75A","3oxxB-2fr5A:undetectable","3oxxB-2fr5A:19.31"],["3OXX_A_DR7A100_2","2g0f","Escherichia coli","THIOL:DISULFIDE INTERCHANGE PROTEIN DSBE","PF08534(Redoxin)",5,"GLY A 139;VAL A 140;PRO A  46;VAL A  45;ILE A 155","None","1.11A","3oxxB-2g0fA:undetectable","3oxxB-2g0fA:18.34"],["3OXX_A_DR7A100_2","2gwn","Porphyromonas gingivalis","DIHYDROOROTASE","PF01979(Amidohydro_1)",5,"ALA A 121;ILE A  60;GLY A  58;VAL A 386;VAL A 336","None","1.25A","3oxxB-2gwnA:undetectable","3oxxB-2gwnA:14.00"],["3OXX_A_DR7A100_2","2h88","Gallus gallus","SUCCINATE DEHYDROGENASE FLAVOPROTEIN SUBUNIT","PF00890(FAD_binding_2);PF02910(Succ_DH_flav_C)",5,"ARG A 269;LEU A 323;ASP A 351;VAL A 359;ILE A 357","None","1.27A","3oxxB-2h88A:undetectable","3oxxB-2h88A:9.38"],["3OXX_A_DR7A100_2","2hzg","Rhodobacter sphaeroides","MANDELATE RACEMASE\/MUCONATE LACTONIZING ENZYME\/ENOLASE SUPERFAMILY","PF02746(MR_MLE_N);PF13378(MR_MLE_C)",5,"LEU A 310;ALA A  28;ASP A  27;VAL A 366;ILE A 341","None","0.97A","3oxxB-2hzgA:undetectable","3oxxB-2hzgA:12.69"],["3OXX_A_DR7A100_2","2hzk","Rhodobacter sphaeroides","TRAP-T FAMILY SORBITOL\/MANNITOL TRANSPORTER, PERIPLASMIC BINDING PROTEIN, SMOM","PF03480(DctP)",5,"ALA A 147;GLY A  98;VAL A  97;VAL A  86;ILE A 145","None","1.24A","3oxxB-2hzkA:undetectable","3oxxB-2hzkA:13.81"],["3OXX_A_DR7A100_2","2rkf","Human immunodeficiency virus 1","PROTEASE RETROPEPSIN","PF00077(RVP)",8,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  29;GLY A  49;PRO A  81;ILE A  84","AB1 A 501 ( 4.7A);None;AB1 A 501 (-2.4A);AB1 A 501 (-3.5A);AB1 A 501 ( 3.3A);AB1 A 501 (-3.5A);AB1 A 501 (-4.2A);AB1 A 501 ( 4.2A)","0.32A","3oxxB-2rkfA:20.8","3oxxB-2rkfA:83.84"],["3OXX_A_DR7A100_2","2rsp","Rous sarcoma virus","RSV PROTEASE","PF00077(RVP)",5,"ARG A  10;LEU A  35;ASP A  37;ALA A  40;ASP A  41","None","0.84A","3oxxB-2rspA:13.2","3oxxB-2rspA:32.00"],["3OXX_A_DR7A100_2","2rsp","Rous sarcoma virus","RSV PROTEASE","PF00077(RVP)",6,"ARG A 105;LEU A  35;ASP A  37;ALA A  40;ASP A  41;ILE A 108","None","1.47A","3oxxB-2rspA:13.2","3oxxB-2rspA:32.00"],["3OXX_A_DR7A100_2","2v3c","Methanocaldococcus jannaschii","SIGNAL RECOGNITION 54 KDA PROTEIN","PF00448(SRP54);PF02881(SRP54_N);PF02978(SRP_SPB)",5,"ALA C 136;ASP C 137;PRO C 212;VAL C 102;ILE C 187","None","1.34A","3oxxB-2v3cC:undetectable","3oxxB-2v3cC:13.27"],["3OXX_A_DR7A100_2","2vz9","Sus scrofa","FATTY ACID SYNTHASE","PF00107(ADH_zinc_N);PF00109(ketoacyl-synt);PF00698(Acyl_transf_1);PF02801(Ketoacyl-synt_C);PF08242(Methyltransf_12);PF08659(KR);PF14765(PS-DH);PF16197(KAsynt_C_assoc)",5,"LEU A 567;ALA A 590;ASP A 591;GLY A 579;ILE A 564","None","1.23A","3oxxB-2vz9A:undetectable","3oxxB-2vz9A:3.59"],["3OXX_A_DR7A100_2","2wdw","Nonomuraea gerenzanensis","PUTATIVE HEXOSE OXIDASE","PF01565(FAD_binding_4);PF08031(BBE)",5,"ALA A  73;ASP A  72;VAL A 187;VAL A  86;ILE A 106","None;None;None;FAD A 601 (-4.2A);None","1.21A","3oxxB-2wdwA:undetectable","3oxxB-2wdwA:15.35"],["3OXX_A_DR7A100_2","2wu5","Escherichia coli","SUCCINATE DEHYDROGENASE FLAVOPROTEIN SUBUNIT","PF00890(FAD_binding_2);PF02910(Succ_DH_flav_C)",5,"ARG A 258;LEU A 313;ASP A 341;VAL A 349;ILE A 347","None","1.12A","3oxxB-2wu5A:undetectable","3oxxB-2wu5A:10.21"],["3OXX_A_DR7A100_2","2xua","Paraburkholderia xenovorans","3-OXOADIPATE ENOL-LACTONASE","PF12146(Hydrolase_4)",5,"ARG A  61;LEU A  78;ALA A 196;ASP A 197;ILE A  75","None","1.23A","3oxxB-2xuaA:undetectable","3oxxB-2xuaA:17.70"],["3OXX_A_DR7A100_2","2zc8","Thermus thermophilus","N-ACYLAMINO ACID RACEMASE","PF02746(MR_MLE_N);PF13378(MR_MLE_C)",5,"ARG A  35;LEU A 351;ALA A 294;VAL A 356;ILE A 327","None","1.27A","3oxxB-2zc8A:undetectable","3oxxB-2zc8A:14.57"],["3OXX_A_DR7A100_2","3a31","Aeropyrum pernix","PROBABLE THREONYL-TRNA SYNTHETASE 1","PF00587(tRNA-synt_2b);PF03129(HGTP_anticodon)",5,"ALA A 438;ASP A 437;VAL A 445;VAL A 343;ILE A 363","None","1.12A","3oxxB-3a31A:undetectable","3oxxB-3a31A:12.69"],["3OXX_A_DR7A100_2","3dmo","Burkholderia pseudomallei","CYTIDINE DEAMINASE","PF00383(dCMP_cyt_deam_1)",5,"ARG A  92;GLY A  27;VAL A  26;VAL A 105;ILE A  75","None","0.96A","3oxxB-3dmoA:undetectable","3oxxB-3dmoA:23.61"],["3OXX_A_DR7A100_2","3gs9","Listeria monocytogenes","PROTEIN GP18","PF06605(Prophage_tail)",5,"LEU A 157;ASP A 154;PRO A 166;VAL A 164;ILE A 153","None","1.30A","3oxxB-3gs9A:undetectable","3oxxB-3gs9A:14.81"],["3OXX_A_DR7A100_2","3gt7","Syntrophus aciditrophicus","SENSOR PROTEIN","PF00072(Response_reg)",5,"ARG A 102;ALA A 108;ASP A 109;ILE A  59;VAL A  63","None","1.11A","3oxxB-3gt7A:undetectable","3oxxB-3gt7A:23.08"],["3OXX_A_DR7A100_2","3il2","Thermus thermophilus","REDOX-SENSING TRANSCRIPTIONAL REPRESSOR REX","PF02629(CoA_binding);PF06971(Put_DNA-bind_N)",5,"LEU A 145;ALA A  96;ILE A 127;GLY A 125;ILE A  85","None","1.31A","3oxxB-3il2A:undetectable","3oxxB-3il2A:23.67"],["3OXX_A_DR7A100_2","3it4","Mycobacterium tuberculosis","ARGININE BIOSYNTHESIS BIFUNCTIONAL PROTEIN ARGJ ALPHA CHAIN;ARGININE BIOSYNTHESIS BIFUNCTIONAL PROTEIN ARGJ BETA CHAIN","PF01960(ArgJ)",5,"ASP B 241;ILE A 130;GLY A 128;PRO A  64;VAL A  65","None","0.97A","3oxxB-3it4B:undetectable","3oxxB-3it4B:19.90"],["3OXX_A_DR7A100_2","3l2z","Mycobacterium tuberculosis","BIRA BIFUNCTIONAL PROTEIN","PF02237(BPL_C);PF03099(BPL_LplA_LipB)",5,"ARG A 189;LEU A 116;ASP A 175;VAL A 132;ILE A 117","None","1.23A","3oxxB-3l2zA:undetectable","3oxxB-3l2zA:18.01"],["3OXX_A_DR7A100_2","3mws","Human immunodeficiency virus 1","HIV-1 PROTEASE","PF00077(RVP)",9,"LEU A  23;ASP A  25;ALA A  28;ASP A  29;ILE A  47;GLY A  49;PRO A  81;VAL A  82;ILE A  84","None","0.41A","3oxxB-3mwsA:19.9","3oxxB-3mwsA:74.75"],["3OXX_A_DR7A100_2","3n0w","Paraburkholderia xenovorans","ABC BRANCHED CHAIN AMINO ACID FAMILY TRANSPORTER, PERIPLASMIC LIGAND BINDING PROTEIN","PF13458(Peripla_BP_6)",5,"ARG A  86;LEU A 112;ALA A 120;GLY A  30;ILE A 109","None","1.14A","3oxxB-3n0wA:undetectable","3oxxB-3n0wA:14.05"],["3OXX_A_DR7A100_2","3pdi","Azotobacter vinelandii","NITROGENASE MOFE COFACTOR BIOSYNTHESIS PROTEIN NIFE","PF00148(Oxidored_nitro)",5,"ASP A 131;ALA A  98;ASP A  92;ILE A  94;ILE A 129","None","1.13A","3oxxB-3pdiA:undetectable","3oxxB-3pdiA:11.45"],["3OXX_A_DR7A100_2","3s1s","Bacillus pumilus","RESTRICTION ENDONUCLEASE BPUSI","PF02384(N6_Mtase);PF15516(BpuSI_N)",5,"LEU A 361;ASP A 327;ILE A 351;VAL A 243;ILE A 384","None;None;None;EDO A 913 (-3.8A);EDO A 913 (-4.2A)","1.36A","3oxxB-3s1sA:undetectable","3oxxB-3s1sA:7.39"],["3OXX_A_DR7A100_2","3t3c","Human immunodeficiency virus 1","HIV-1 PROTEASE","PF00077(RVP)",7,"LEU A  23;ASP A  25;ALA A  28;ASP A  29;ILE A  47;GLY A  49;PRO A  81","SO4 A 101 (-4.2A);017 A 201 (-2.6A);017 A 201 (-3.5A);017 A 201 (-3.5A);None;017 A 201 (-4.0A);None","0.70A","3oxxB-3t3cA:18.6","3oxxB-3t3cA:74.75"],["3OXX_A_DR7A100_2","3t3c","Human immunodeficiency virus 1","HIV-1 PROTEASE","PF00077(RVP)",5,"LEU A  23;ASP A  25;ALA A  28;ASP A  30;GLY A  49","SO4 A 101 (-4.2A);017 A 201 (-2.6A);017 A 201 (-3.5A);017 A 201 (-4.2A);017 A 201 (-4.0A)","1.25A","3oxxB-3t3cA:18.6","3oxxB-3t3cA:74.75"],["3OXX_A_DR7A100_2","3ttp","Human immunodeficiency virus 1","HIV-1 PROTEASE","PF00077(RVP)",7,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  29;GLY A  49;PRO A  81","017 A 201 ( 4.8A);None;017 A 201 (-2.6A);017 A 201 (-3.4A);017 A 201 (-3.3A);017 A 201 (-3.0A);017 A 201 (-4.1A)","0.45A","3oxxB-3ttpA:19.9","3oxxB-3ttpA:78.79"],["3OXX_A_DR7A100_2","3ttp","Human immunodeficiency virus 1","HIV-1 PROTEASE","PF00077(RVP)",7,"LEU A  23;ASP A  25;ALA A  28;ASP A  29;GLY A  49;PRO A  81;ILE A  84","None;017 A 201 (-2.6A);017 A 201 (-3.4A);017 A 201 (-3.3A);017 A 201 (-3.0A);017 A 201 (-4.1A);017 A 201 (-4.7A)","0.31A","3oxxB-3ttpA:19.9","3oxxB-3ttpA:78.79"],["3OXX_A_DR7A100_2","3u7s","Human immunodeficiency virus 1","POL POLYPROTEIN","PF00077(RVP)",8,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  29;ILE A  47;GLY A  49;PRO A  81","None;None;017 A 202 ( 2.5A);017 A 201 (-3.4A);017 A 201 (-3.2A);017 A 202 (-3.6A);017 A 202 (-2.9A);017 A 202 (-4.0A)","0.46A","3oxxB-3u7sA:20.1","3oxxB-3u7sA:77.78"],["3OXX_A_DR7A100_2","3u7s","Human immunodeficiency virus 1","POL POLYPROTEIN","PF00077(RVP)",6,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  30;GLY A  49","None;None;017 A 202 ( 2.5A);017 A 201 (-3.4A);017 A 201 ( 4.0A);017 A 202 (-2.9A)","1.44A","3oxxB-3u7sA:20.1","3oxxB-3u7sA:77.78"],["3OXX_A_DR7A100_2","3uhl","Human immunodeficiency virus 1","PROTEASE","PF00077(RVP)",6,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  29;VAL A  82","None","0.70A","3oxxB-3uhlA:16.1","3oxxB-3uhlA:77.78"],["3OXX_A_DR7A100_2","3uhl","Human immunodeficiency virus 1","PROTEASE","PF00077(RVP)",6,"LEU A  23;ASP A  25;ALA A  28;ASP A  29;PRO A  81;VAL A  82","None","0.54A","3oxxB-3uhlA:16.1","3oxxB-3uhlA:77.78"],["3OXX_A_DR7A100_2","3vrb","Ascaris suum","FLAVOPROTEIN SUBUNIT OF COMPLEX II","PF00890(FAD_binding_2);PF02910(Succ_DH_flav_C)",5,"ARG A 292;LEU A 346;ASP A 374;VAL A 382;ILE A 380","None","1.11A","3oxxB-3vrbA:undetectable","3oxxB-3vrbA:9.61"],["3OXX_A_DR7A100_2","3zpc","Acinetobacter baumannii","RIBOFLAVIN BIOSYNTHESIS PROTEIN RIBD","PF00383(dCMP_cyt_deam_1);PF01872(RibD_C)",5,"LEU A 242;ASP A 204;GLY A 197;VAL A 248;ILE A 241","None","0.88A","3oxxB-3zpcA:undetectable","3oxxB-3zpcA:15.71"],["3OXX_A_DR7A100_2","4axv","Vibrio campbellii","MPAA","PF04952(AstE_AspA)",5,"LEU A 174;ALA A 225;ASP A 224;GLY A  57;VAL A 208","None","1.00A","3oxxB-4axvA:undetectable","3oxxB-4axvA:16.60"],["3OXX_A_DR7A100_2","4dr9","Synechococcus elongatus","PEPTIDE DEFORMYLASE","PF01327(Pep_deformylase)",5,"LEU A  51;ASP A  41;ILE A  39;VAL A  75;ILE A  47","None","1.18A","3oxxB-4dr9A:undetectable","3oxxB-4dr9A:19.02"],["3OXX_A_DR7A100_2","4e4j","Mycoplasma penetrans","ARGININE DEIMINASE","PF02274(Amidinotransf)",5,"LEU A 109;GLY A  62;PRO A 444;VAL A  67;ILE A 114","None","1.00A","3oxxB-4e4jA:undetectable","3oxxB-4e4jA:12.21"],["3OXX_A_DR7A100_2","4fe9","Bacteroides thetaiotaomicron","OUTER MEMBRANE PROTEIN SUSF","PF16411(SusF_SusE);PF17142(DUF5115)",5,"LEU A 387;ILE A 453;GLY A 482;VAL A 427;ILE A 429","None","1.14A","3oxxB-4fe9A:undetectable","3oxxB-4fe9A:14.06"],["3OXX_A_DR7A100_2","4g1g","Avian avulavirus 1","MATRIX PROTEIN","PF00661(Matrix)",5,"LEU A 322;ALA A 320;ILE A 314;VAL A 208;ILE A 210","None","0.99A","3oxxB-4g1gA:undetectable","3oxxB-4g1gA:14.70"],["3OXX_A_DR7A100_2","4j5u","Rickettsia rickettsii","SERINE HYDROXYMETHYLTRANSFERASE","PF00464(SHMT)",5,"ALA A 333;ASP A 337;ILE A 341;VAL A 320;ILE A 361","None","1.32A","3oxxB-4j5uA:undetectable","3oxxB-4j5uA:14.11"],["3OXX_A_DR7A100_2","4lcb","Acidianus hospitalis","CELL DIVISION PROTEIN CDVC, VPS4","PF00004(AAA);PF09336(Vps4_C)",5,"LEU A 133;ALA A 108;PRO A 265;VAL A 264;ILE A 262","None","1.21A","3oxxB-4lcbA:undetectable","3oxxB-4lcbA:13.42"],["3OXX_A_DR7A100_2","4lhu","Homo sapiens","9C2 TCR DELTA CHAIN","PF07654(C1-set);PF07686(V-set)",5,"LEU D  84;ASP D  88;ILE D  52;GLY D  64;ILE D  81","None","1.30A","3oxxB-4lhuD:undetectable","3oxxB-4lhuD:18.83"],["3OXX_A_DR7A100_2","4njv","Human immunodeficiency virus 1","PROTEASE","PF00077(RVP)",9,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  29;ILE A  47;GLY A  49;PRO A  81;ILE A  84","RIT A 500 (-3.2A);None;RIT A 500 (-2.4A);RIT A 500 (-3.6A);RIT A 500 (-3.2A);RIT A 500 ( 4.5A);RIT A 500 (-3.4A);RIT A 500 (-3.9A);RIT A 500 (-4.3A)","0.36A","3oxxB-4njvA:20.8","3oxxB-4njvA:84.85"],["3OXX_A_DR7A100_2","4ox8","Prochlorococcus marinus","CARBON DIOXIDE-CONCENTRATING MECHANISM PROTEIN CCMK","PF00936(BMC)",5,"ALA A  66;GLY A  75;VAL A  72;VAL A  49;ILE A  13","None","1.05A","3oxxB-4ox8A:undetectable","3oxxB-4ox8A:19.40"],["3OXX_A_DR7A100_2","4pxn","Zea mays","UNCHARACTERIZED PROTEIN","PF00171(Aldedh)",5,"LEU A 307;ALA A 292;ILE A 455;VAL A 276;ILE A 274","None","1.03A","3oxxB-4pxnA:undetectable","3oxxB-4pxnA:11.35"],["3OXX_A_DR7A100_2","4qfb","Chlamydia trachomatis","CT263","no annotation",5,"LEU A  18;ALA A 183;ILE A 156;GLY A  71;VAL A  42","None","1.27A","3oxxB-4qfbA:undetectable","3oxxB-4qfbA:15.23"],["3OXX_A_DR7A100_2","4r37","Bacteroides fragilis","PUTATIVE ACYL-[ACYL-CARRIER-PROTEIN]--UDP-N-ACETYLGLUCOSAMINE O-ACYLTRANSFERASE","PF00132(Hexapep);PF13720(Acetyltransf_11)",5,"LEU A 110;ALA A  60;ILE A  44;GLY A  63;ILE A  86","None","0.98A","3oxxB-4r37A:undetectable","3oxxB-4r37A:21.55"],["3OXX_A_DR7A100_2","4tqv","Sphingomonas sp.","ALGM1;ALGM2","PF00528(BPD_transp_1)",5,"ILE A 147;GLY A 150;VAL A 153;VAL B 259;ILE B 263","None","1.14A","3oxxB-4tqvA:undetectable","3oxxB-4tqvA:14.90"],["3OXX_A_DR7A100_2","4ydf","Primate T-lymphotropic virus 1","HTLV-1 PROTEASE","PF00077(RVP)",7,"ARG A  10;LEU A  30;ASP A  32;ALA A  35;ASP A  36;GLY A  58;ILE A 100","None;None;4B1 A 201 (-2.9A);4B1 A 201 (-3.6A);4B1 A 201 (-4.4A);4B1 A 201 (-3.4A);4B1 A 201 (-4.8A)","0.55A","3oxxB-4ydfA:13.1","3oxxB-4ydfA:33.33"],["3OXX_A_DR7A100_2","4zqi","Yersinia pestis","D-ALANINE--D-ALANINE LIGASE","PF01820(Dala_Dala_lig_N);PF07478(Dala_Dala_lig_C)",5,"LEU A   8;GLY A  87;VAL A  88;VAL A  58;ILE A  60","None","1.02A","3oxxB-4zqiA:undetectable","3oxxB-4zqiA:16.33"],["3OXX_A_DR7A100_2","5b18","Human immunodeficiency virus 1","PROTEASE","PF00077(RVP)",5,"ALA A  28;ASP A  29;GLY A  49;VAL A  50;ILE A  84","None","0.84A","3oxxB-5b18A:18.3","3oxxB-5b18A:76.77"],["3OXX_A_DR7A100_2","5b18","Human immunodeficiency virus 1","PROTEASE","PF00077(RVP)",5,"ALA A  28;ASP A  29;VAL A  50;PRO A  81;ILE A  84","None","1.29A","3oxxB-5b18A:18.3","3oxxB-5b18A:76.77"],["3OXX_A_DR7A100_2","5b18","Human immunodeficiency virus 1","PROTEASE","PF00077(RVP)",5,"ARG A   8;ALA A  28;ASP A  29;GLY A  49;ILE A  84","None","0.81A","3oxxB-5b18A:18.3","3oxxB-5b18A:76.77"],["3OXX_A_DR7A100_2","5b18","Human immunodeficiency virus 1","PROTEASE","PF00077(RVP)",5,"ARG A   8;ALA A  28;ASP A  29;PRO A  81;ILE A  84","None","0.52A","3oxxB-5b18A:18.3","3oxxB-5b18A:76.77"],["3OXX_A_DR7A100_2","5brq","Bacillus licheniformis","GLYCOSIDE HYDROLASE FAMILY 13","PF00128(Alpha-amylase);PF16657(Malt_amylase_C)",5,"ASP A  83;ILE A  36;GLY A  31;VAL A  30;ILE A  56","None;None; MG A 601 ( 4.6A); MG A 601 (-4.8A);None","0.92A","3oxxB-5brqA:undetectable","3oxxB-5brqA:10.25"],["3OXX_A_DR7A100_2","5hm7","Homo sapiens","BUTYROPHILIN SUBFAMILY 3 MEMBER A1","PF00622(SPRY);PF13765(PRY)",5,"LEU A 434;ALA A 310;ASP A 311;ILE A 480;VAL A 381","None","1.28A","3oxxB-5hm7A:undetectable","3oxxB-5hm7A:14.52"],["3OXX_A_DR7A100_2","5j32","Arabidopsis thaliana","3-ISOPROPYLMALATE DEHYDROGENASE 2, CHLOROPLASTIC","PF00180(Iso_dh)",5,"ALA A 324;ASP A 326;PRO A 335;VAL A  57;ILE A  53","None","1.34A","3oxxB-5j32A:undetectable","3oxxB-5j32A:14.40"],["3OXX_A_DR7A100_2","5lyk","Homo sapiens","BUTYROPHILIN SUBFAMILY 3 MEMBER A1","PF00622(SPRY);PF13765(PRY)",5,"LEU A 464;ALA A 340;ASP A 341;ILE A 510;VAL A 411","None","1.34A","3oxxB-5lykA:undetectable","3oxxB-5lykA:15.76"],["3OXX_A_DR7A100_2","5m72","Homo sapiens","SIGNAL RECOGNITION PARTICLE SUBUNIT SRP72","PF17004(SRP_TPR_like)",5,"ASP A  44;ALA A  47;PRO A  12;VAL A  11;ILE A  37","None","1.11A","3oxxB-5m72A:undetectable","3oxxB-5m72A:20.51"],["3OXX_A_DR7A100_2","5t2z","Human immunodeficiency virus 1","PROTEASE","PF00077(RVP)",9,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  29;ILE A  47;GLY A  49;PRO A  81;ILE A  84","None","0.37A","3oxxB-5t2zA:20.0","3oxxB-5t2zA:77.78"],["3OXX_A_DR7A100_2","5t2z","Human immunodeficiency virus 1","PROTEASE","PF00077(RVP)",6,"ARG A   8;LEU A  23;ASP A  25;ALA A  28;ASP A  30;GLY A  49","None","1.47A","3oxxB-5t2zA:20.0","3oxxB-5t2zA:77.78"],["3OXX_A_DR7A100_2","5wxv","Vibrio anguillarum","ISOCHORISMATE LYASE","no annotation",5,"LEU A  59;ALA A 178;ASP A 179;GLY A 174;VAL A 173","None","1.13A","3oxxB-5wxvA:undetectable","3oxxB-5wxvA:20.20"],["3OXX_A_DR7A100_2","5y0q","Bacillus subtilis","UPF0348 PROTEIN B4417_3650","no annotation",5,"LEU A  70;ALA A 332;VAL A 360;VAL A  36;ILE A  89","None","1.24A","3oxxB-5y0qA:undetectable","3oxxB-5y0qA:undetectable"],["3OXX_A_DR7A100_2","6c0d","Paraburkholderia phymatum","AMIDASE, HYDANTOINASE\/CARBAMOYLASE FAMILY","no annotation",5,"ALA A 342;ASP A 343;PRO A 376;VAL A 375;ILE A 202","None;SO4 A 504 (-4.1A);EDO A 509 ( 4.5A);None;None","1.23A","3oxxB-6c0dA:undetectable","3oxxB-6c0dA:20.79"],["3OXX_A_DR7A100_2","6cc2","Entamoeba histolytica","CELL DIVISION CONTROL PROTEIN 45 CDC45 PUTATIVE","no annotation",5,"ALA A 357;ILE A 213;GLY A 362;VAL A  37;ILE A 206","None","1.13A","3oxxB-6cc2A:undetectable","3oxxB-6cc2A:21.90"],["3OXX_A_DR7A100_2","6fiv","Feline immunodeficiency virus","RETROPEPSIN","PF00077(RVP)",7,"ARG A  13;LEU A  28;ASP A  30;ALA A  33;ASP A  34;GLY A  58;VAL A  59","None;None;3TL A 201 (-3.5A);3TL A 201 (-4.0A);3TL A 201 (-3.9A);3TL A 201 (-3.4A);3TL A 201 (-4.3A)","0.38A","3oxxB-6fivA:15.4","3oxxB-6fivA:30.70"],["3OXX_A_DR7A100_2","6fiv","Feline immunodeficiency virus","RETROPEPSIN","PF00077(RVP)",7,"ARG A  13;LEU A  28;ASP A  30;ALA A  33;ASP A  34;VAL A  59;VAL A  99","None;None;3TL A 201 (-3.5A);3TL A 201 (-4.0A);3TL A 201 (-3.9A);3TL A 201 (-4.3A);None","0.56A","3oxxB-6fivA:15.4","3oxxB-6fivA:30.70"],["3OXX_A_DR7A100_2","6upj","Human immunodeficiency virus 2","HIV-2 PROTEASE","PF00077(RVP)",7,"LEU A  23;ASP A  25;ALA A  28;ASP A  29;GLY A  49;PRO A  81;ILE A  84","None;NIU A 100 (-2.8A);NIU A 100 (-3.6A);None;NIU A 100 ( 3.8A);None;None","0.65A","3oxxB-6upjA:18.2","3oxxB-6upjA:48.48"]]